Psych PeerView On-Demand Learning Hub

Resources for healthcare professionals who are prescribing for appropriate adult patients living with schizophrenia or for maintenance monotherapy treatment of bipolar I disorder.

Welcome to Psych PeerView. Here, you will learn from healthcare professionals like yourself discussing their real experiences with the treatment of schizophrenia or the maintenance monotherapy of bipolar I disorder in appropriate adult patients.

WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS

Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at increased risk of death (1.6 to 1.7 times) compared to placebo-treated patients. ABILIFY ASIMTUFII and ABILIFY MAINTENA are not approved for the treatment of patients with dementia-related psychosis.

Be sure to check back frequently for refreshed content.

Expert Perspectives: An Additional LAI Treatment Option

The mechanism of action of aripiprazole in the treatment of schizophrenia and bipolar I disorder is unknown. Join Roger McIntyre, MD, FRCPC, Erin Crown, PA-C, and Jelena Kunovac, MD, MS in conversation about the addition of ABILIFY ASIMTUFII® (aripiprazole) to the treatment toolbox for patients living with schizophrenia or bipolar I disorder.

An LAI Option for Appropriate Adult Patients Living With Schizophrenia

Join Leslie Citrome, MD, MPH, and Brooke Kempf, PMHNP, as they discuss ABILIFY MAINTENA® (aripiprazole) as a treatment option for appropriate adult patients with schizophrenia.

How Do You Approach the Idea of an LAI as a Maintenance Treatment for Adults With Bipolar I Disorder?

Listen in as Roger McIntyre, MD, FRCPC, and Erin Crown, PA-C, introduce ABILIFY MAINTENA, an LAI with the potential to be a maintenance treatment option for bipolar I disorder in their appropriate adult patients.

LAIs as an Option for Adult Patients Living With Schizophrenia

Which patients could be potential candidates for an LAI? Leslie Citrome, MD, MPH, and Brooke Kempf, PMHNP, reveal some factors they consider when determining this treatment option for adult patients living with schizophrenia.

Common Hurdles in Treating Adult Patients With Schizophrenia and Maintenance Phase Bipolar I Disorder

How do you navigate treatment challenges for appropriate adult patients with schizophrenia or the maintenance phase of bipolar l disorder? Leslie Citrome, MD, MPH, and Brooke Kempf, PMHNP, share which methods were successful for them.

Discussing Misconceptions About LAIs

Roger McIntyre, MD, FRCPC, and Erin Crown, PA-C, discuss some misconceptions they have heard regarding LAIs.

LAIs as an Option for Adult Patients Living With Maintenance Phase Bipolar I Disorder

When and how do you talk to your appropriate adult patients living with bipolar I disorder about LAIs? Roger McIntyre, MD, FRCPC, and Erin Crown, PA-C, share their thoughts for providing this as a treatment option.

A Shared Approach: Bringing the Patient Into the Treatment Conversation

Roger McIntyre, MD, FRCPC, and Erin Crown, PA-C, help patients feel more involved by including them in conversations about available treatment options such as LAIs. Find out how they start the conversation.

LAI=long-acting injectable.